Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment EP News Bureau Dec 26, 2022 Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…
Glenmark announces top-line results from Phase 3 clinical trial of favipiravir for COVID-19… EP News Bureau Jul 22, 2020 The study evaluated the efficacy and safety of favipiravir plus standard supportive care, versus standard supportive care alone,…
